Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Understanding hope in patients with Multiple Sclerosis.
Promising New Approaches to Assess Cognitive Functioning in People with Multiple Sclerosis.
Selective ORAI1 Inhibition Ameliorates Autoimmune Central Nervous System Inflammation by Suppressing Effector but Not Regulatory T Cell Function.
Regulatory Lymphocytes Are Key Factors in MHC-Independent Resistance to EAE.
Inflammatory demyelinating central nervous system diseases in childhood: clinical and paraclinical profiles in 133 patients.
Update on monitoring and adverse effects of approved second-generation disease-modifying therapies in relapsing forms of multiple sclerosis.
Degenerative Cervical Myelopathy: A Spectrum of Related Disorders Affecting the Aging Spine.
Decrease of mutual information in brain electrical activity of patients with relapsing-remitting multiple sclerosis.
[Vitamin D and neurology.]
Reading, writing, and reserve: Literacy activities are linked to hippocampal volume and memory in multiple sclerosis.
Nationwide Incidence of Acquired Central Nervous System Demyelination in Icelandic Children.
Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS). (REFINE)
[Progressive multifocal leukoencephalopathy as a complication of natalizumab therapy].
The Inflammasome Pyrin Contributes to Pertussis Toxin-Induced IL-1β Synthesis, Neutrophil Intravascular Crawling and Autoimmune Encephalomyelitis.
Correlation between brain volume change and T2 relaxation time induced by dehydration and rehydration: Implications for monitoring atrophy in clinical studies.
[PET-patterns of cognitive impairment in patients with multiple sclerosis.]
The Non-Obese Diabetic Mouse Strain as a Model to Study CD8(+) T Cell Function in Relapsing and Progressive Multiple Sclerosis.
Concomitant analysis of arterial, venous, and CSF flows using phase-contrast MRI: a quantitative comparison between MS patients and healthy controls.
Neurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosis.
The Disease-Ameliorating Function of Autoregulatory CD8 T Cells Is Mediated by Targeting of Encephalitogenic CD4 T Cells in Experimental Autoimmune Encephalomyelitis.
Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP).
Vagomimetic effects of fingolimod: physiology and clinical implications.
Neurogenic vision loss: Causes and outcome. An experience from a tertiary center in Northern India.
Analysis of macular OCT images using deformable registration.
Local overexpression of interleukin-11 in the central nervous system limits demyelination and enhances remyelination.
Pages
« first
‹ previous
…
479
480
481
482
483
484
485
486
487
…
next ›
last »